Sarcoma of the Female Genitalia: Volume 2 Other Rare Sarcomas, Mixed Tumors, Genital Sarcomas and Pregnancy

Foreword\nContents\nList of abbreviations\nDefinition of cytoreduction, NCCN-Guidelines\nImmunohistochemistry table\n1 Angiosarcoma\n	1.1 Uterine angiosarcoma\n		1.1.1 General, epidemiology, etiology, pathogenesis, staging\n		1.1.2 Macroscopic and microscopic features\n		1.1.3 Clinical presentation, diagnostics, screening\n		1.1.4 Imaging\n		1.1.5 Differential diagnostics\n		1.1.6 Course, prognosis\n		1.1.7 Primary surgery\n		1.1.8 Adjuvant and additive radio-, chemo- and hormone therapy\n		1.1.9 Primary radio-, chemo- and hormone therapy, approach in cases of general inoperability\n		1.1.10 Aftercare, recurrences, metastases\n		1.1.11 Surgery and postoperative additive therapy for recurrences and metastases\n		1.1.12 Palliative radio-, chemo- and hormone therapy, small molecule therapy, supportive therapy\n	1.2 Extrauterine angiosarcomas\n		1.2.1 Angiosarcomas of the vulva and the vagina\n		1.2.2 Angiosarcoma of the ovary and the tuba uterina\n2 Liposarcoma\n	2.1 Uterine liposarcoma\n		2.1.1 General, epidemiology, etiology, pathogenesis, staging\n		2.1.2 Macroscopic and microscopic features\n		2.1.3 Clinical presentation, diagnostics, screening\n		2.1.4 Imaging\n		2.1.5 Differential diagnostics\n		2.1.6 Course, prognosis\n		2.1.7 Primary surgery\n		2.1.8 Adjuvant and additive radio-, chemo- and hormone therapy\n		2.1.9 Primary radio-, chemo- and hormone therapy, approach in cases of general inoperability\n		2.1.10 Aftercare, recurrences, metastases\n		2.1.11 Surgical management of and postoperative additive therapy for recurrences and metastatic disease\n		2.1.12 Palliative radio-, chemo- and hormone therapy, therapy with small molecules, supportive therapy\n	2.2 Extrauterine liposarcomas\n		2.2.1 Liposarcoma of the vulva and the vagina\n		2.2.2 Peritoneal liposarcoma\n3 Rhabdomyosarcoma\n	3.1 Uterine rhabdomyosarcoma\n		3.1.1 General, epidemiology, etiology, pathogenesis, staging\n		3.1.2 Macroscopic and microscopic features\n		3.1.3 Clinical presentation, diagnostics, screening\n		3.1.4 Imaging\n		3.1.5 Differential diagnostics\n		3.1.6 Course, prognosis\n		3.1.7 Primary surgery\n		3.1.8 Adjuvant and additive radio-, chemo- and hormone therapy\n		3.1.9 Primary radiation, hormone and chemotherapy, approach in cases of general inoperability\n		3.1.10 Aftercare, recurrences, metastases\n		3.1.11 Surgical management and postoperative additive therapy for recurrences and metastatic disease\n		3.1.12 Palliative radiotherapy, chemotherapy and hormone therapy, therapy with small molecules\n	3.2 Extrauterine rhabdomyosarcoma\n		3.2.1 Rhabdomyosarcoma of the ovary and the fallopian tube\n		3.2.2 Rhabdomyosarcomas of the vulva and the vagina\n4 Perivascular epithelioid cell tumor (PEComa)\n	4.1 PEComa of the uterus\n		4.1.1 General, epidemiology, etiology, pathogenesis, staging\n		4.1.2 Macroscopic and microscopic features\n		4.1.3 Clinical presentation, diagnostics, screening\n		4.1.4 Imaging\n		4.1.5 Differential diagnostics\n		4.1.6 Course, prognosis\n		4.1.7 Primary surgery\n		4.1.8 Adjuvant and additive radio-, chemo- and hormone therapy\n		4.1.9 Primary radio-, chemo- and hormone therapy, approach in cases of general inoperability\n		4.1.10 Aftercare, recurrences, metastases\n		4.1.11 Surgical management and postoperative additive treatment for recurrences and metastatic disease\n		4.1.12 Palliative radio-, chemo- and hormone therapy, therapy with small molecules, supportive therapy\n	4.2 Extrauterine and extragenital PEComas\n		4.2.1 General, pathogenesis, pathologic-anatomical features\n		4.2.2 Clinical presentation, diagnostics, imaging, differential diagnostics\n		4.2.3 Course, prognosis, operative, systemic and radiogenic therapy\n5 Adenofibroma\n	5.1 Uterine adenofibroma\n		5.1.1 General, pathogenesis, pathologico-anatomical features\n		5.1.2 Clinical presentation, diagnostics, imaging, differential diagnostics, screening\n		5.1.3 Course, prognosis, operative, systemic and radiogenic therapy\n		5.1.4 Aftercare, recurrences, metastases and their treatment\n	5.2 Extrauterine adenofibromas\n		5.2.1 Adenofibromas of the ovary and the fallopian tube\n6 Adenosarcoma\n	6.1 Uterine adenosarcoma\n		6.1.1 General, epidemiology, etiology, pathogenesis, staging\n		6.1.2 Macroscopic and microscopic features\n		6.1.3 Clinical presentation, diagnostics, screening\n		6.1.4 Imaging\n		6.1.5 Differential diagnostics\n		6.1.6 Course, prognosis\n		6.1.7 Primary surgery\n		6.1.8 Adjuvant and additive radio-, chemo- and hormone therapy\n		6.1.9 Primary radio-, chemo- and hormone therapy, approach in cases of general inoperability\n		6.1.10 Aftercare, recurrences, metastases\n		6.1.11 Surgical management and postoperative additive therapy for recurrences and metastatic disease\n		6.1.12 Palliative radio-, chemo- and hormone therapy, treatment with small molecules, supportive therapy\n	6.2 Extrauterine and extragenital adenosarcomas\n		6.2.1 Adenosarcomas of the ovary and the fallopian tube\n		6.2.2 Adenosarcoma of the vagina\n		6.2.3 Extragenital adenosarcomas\n7 Carcinosarcoma\n	7.1 Uterine carcinosarcoma\n		7.1.1 General, epidemiology, etiology, pathogenesis, staging\n		7.1.2 Macroscopic and microscopic features\n		7.1.3 Clinical presentation, diagnostics, screening\n		7.1.4 Imaging\n		7.1.5 Differential diagnostics\n		7.1.6 Course, prognosis\n		7.1.7 Primary surgery\n		7.1.8 Adjuvant and additive radio-, chemo- and hormone therapy\n		7.1.9 Primary radio-, chemo- and hormone therapy, approach in case of general inoperability\n		7.1.10 Aftercare, recurrences, metastases\n		7.1.11 Surgical and postoperative additive treatment for recurrences and metastatic disease\n		7.1.12 Palliative radio-, chemo- and hormone therapy, therapy with small molecules, supportive therapy\n	7.2 Extrauterine carcinosarcoma\n		7.2.1 Carcinosarcoma of the ovary\n		7.2.2 Carcinosarcoma of the fallopian tube\n		7.2.3 Peritoneal carcinosarcoma\n		7.2.4 Extraperitoneal carcinosarcoma\n8 Fertility and pregnancy and variants of leiomyoma, smooth muscle tumors of unclear malignant potential, stromal tumors, genital sarcomas, PEComas and mixed tumors\n	8.1 General, symptoms, clinical presentation, diagnostics, differential diagnostics, prognosis\n	8.2 Disseminated (diffuse) peritoneal leiomyomatosis\n	8.3 Intravenous (intravascular) leiomyomatosis\n	8.4 Benign metastasizing leiomyomas\n	8.5 Leiomyoma and its variants\n	8.6 Smooth muscle tumors of uncertain malignant potential\n	8.7 Leiomyosarcoma\n	8.8 Endometrial stromal nodules and uterine tumors with sex cord-like elements type I and II (ESTSCLE and UTROSCT)\n	8.9 Low-grade endometrial stromal sarcoma\n	8.10 High-grade endometrial stromal sarcomas and undifferentiated uterine sarcomas\n	8.11 Angiosarcoma\n	8.12 Liposarcoma\n	8.13 Rhabdomyosarcoma\n	8.14 PEComa\n	8.15 Adenofibroma\n	8.16 Adenosarcoma\n	8.17 Carcinosarcoma\nIndex